Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Spencer Robert BerthelsenIndependent Director | -8,00k | 410,00k | Derivative Exercise and Sale | 24,42 - 75,67 | 156,08k | - |
| 2026-05-13 | Dr. Brett P. MoniaFounder, CEO & Director | -4,54k | 208,14k | Derivative Exercise and Sale | 32,60 - 78,68 | 242,66k | - |
| 2026-05-04 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -77,29k | 2,03M | Derivative Exercise and Sale | 38,06 - 75,58 | 36,33k | - |
| 2026-05-01 | Mr. Joseph KleinIndependent Director | -10,11k | 266,91k | Derivative Exercise and Sale | 47,11 - 74,45 | 11,11k | - |
| 2026-04-28 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1,63k | 116,73k | Automatic Disposition | 71,79 | 49,26k | -3,20% |
| 2026-04-15 | Ms. B. Lynne ParshallDirector | -5,00k | 381,37k | Automatic Disposition | 76,19 - 76,97 | 51,34k | -8,87% |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -4,90k | 368,49k | Derivative Exercise and Sale | 75,17 | 23,71k | - |
| 2026-04-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 7,32k | 0,00 | Derivative Exercise and Retained Stock | - | 23,71k | 44,69% |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5,62k | 418,95k | Derivative Exercise and Sale | 74,56 | 50,88k | - |
| 2026-04-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 5,22k | 0,00 | Derivative Exercise and Retained Stock | - | 50,88k | 11,43% |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -973,00 | 73,02k | Derivative Exercise and Sale | 75,04 | 67,50k | - |
| 2026-04-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 902,00 | 0,00 | Derivative Exercise and Retained Stock | - | 67,50k | 1,35% |
| 2026-04-01 | Mr. Joseph KleinIndependent Director | -22,32k | 805,60k | Derivative Exercise and Sale | 38,06 - 75,95 | 11,11k | - |
| 2026-04-02 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -6,19k | 458,61k | Automatic Disposition | 74,05 | 16,35k | -27,47% |
| 2026-03-19 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -5,81k | 412,49k | Automatic Disposition | 70,97 | 63,89k | -8,34% |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -175,00k | 3,68M | Derivative Exercise and Sale | 32,60 - 72,38 | 82,66k | - |
| 2026-03-16 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -50,22k | 3,65M | Automatic Disposition | 72,38 - 73,21 | 82,66k | -37,79% |
| 2026-03-10 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -37,28k | 1,16M | Derivative Exercise and Sale | 34,69 - 76,30 | 16,39k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -148,45k | 2,15M | Derivative Exercise and Sale | 60,89 - 76,34 | 242,66k | - |
| 2026-03-09 | Dr. Brett P. MoniaFounder, CEO & Director | -12,32k | 927,65k | Automatic Disposition | 75,26 - 75,58 | 242,66k | -4,83% |
| 2026-03-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10,15k | 763,66k | Automatic Disposition | 75,25 | 62,21k | -14,02% |
| 2026-03-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -1,03k | 43,55k | Derivative Exercise and Sale | 38,06 - 80,33 | 36,33k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -2,14k | 76,45k | Derivative Exercise and Sale | 32,60 - 80,41 | 45,66k | - |
| 2026-03-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -4,52k | 359,25k | Automatic Disposition | 79,36 - 81,01 | 45,66k | -9,01% |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65,09k | 1,65M | Derivative Exercise and Sale | 32,60 - 79,10 | 80,55k | - |
| 2026-03-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20,00k | 1,59M | Automatic Disposition | 79,10 - 80,76 | 80,55k | -19,89% |
| 2026-03-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -20,11k | 873,18k | Derivative Exercise and Sale | 32,60 - 80,84 | 22,54k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -40,32k | 1,59M | Derivative Exercise and Sale | 38,06 - 79,88 | 3,81k | - |
| 2026-03-03 | Ms. Allene Maria DiazIndependent Director | -14,56k | 1,16M | Automatic Disposition | 79,88 - 80,80 | 3,81k | -79,25% |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -16,00k | 616,70k | Derivative Exercise and Sale | 40,05 - 80,00 | 11,11k | - |
| 2026-03-03 | Mr. Joseph KleinIndependent Director | -5,33k | 427,37k | Automatic Disposition | 80,00 - 80,82 | 11,11k | -32,42% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 0,00 | 0,00 | Other Disposition | - | 100,29k | 0,00% |
| 2026-02-11 | Ms. B. Lynne ParshallDirector | -5,00k | 413,59k | Automatic Disposition | 82,72 | 56,34k | -8,15% |
| 2026-02-13 | Dr. Eric E. SwayzeExec. VP of Research | -15,64k | 1,28M | Automatic Disposition | 81,56 - 82,07 | 32,42k | -32,54% |
| 2026-02-06 | Dr. Brett P. MoniaFounder, CEO & Director | -29,43k | 2,52M | Automatic Disposition | 85,79 | 254,50k | -10,37% |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -65,09k | 1,91M | Derivative Exercise and Sale | 32,60 - 83,03 | 100,29k | - |
| 2026-02-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -20,00k | 1,65M | Vendita | 82,60 | 100,29k | -16,63% |
| 2026-01-30 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -6,18k | 513,05k | Vendita | 83,03 | 66,25k | -8,53% |
| 2026-01-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -6,99k | 581,70k | Vendita | 83,24 | 132,88k | -5,00% |
| 2026-01-30 | Dr. Brett P. MoniaFounder, CEO & Director | -62,97k | 5,21M | Vendita | 82,72 | 283,93k | -18,15% |
| 2026-01-30 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -6,18k | 515,63k | Vendita | 83,45 | 69,70k | -8,14% |
| 2026-01-30 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -6,18k | 516,15k | Vendita | 83,53 | 71,98k | -7,91% |
| 2026-01-30 | Dr. Eric E. SwayzeExec. VP of Research | -6,18k | 512,45k | Vendita | 82,93 | 48,07k | -11,39% |
| 2026-01-30 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -5,30k | 439,36k | Vendita | 82,96 | 50,19k | -9,55% |
| 2026-01-30 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5,89k | 488,14k | Vendita | 82,95 | 100,29k | -5,54% |
| 2026-01-22 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3,98k | 323,49k | Automatic Disposition | 81,34 | 22,54k | -15,00% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | 11,54k | 0,00 | Derivative Exercise and Retained Stock | - | 42,25k | 37,59% |
| 2026-01-15 | Dr. Eric E. SwayzeExec. VP of Research | -9,93k | 748,38k | Derivative Exercise and Sale | 75,34 - 75,97 | 42,25k | - |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | 12,38k | 0,00 | Derivative Exercise and Retained Stock | - | 63,89k | 24,04% |
| 2026-01-15 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9,30k | 703,14k | Derivative Exercise and Sale | 75,59 | 63,89k | - |
| 2026-01-15 | Mr. Michael J. YangIndependent Director | 1,93k | 0,00 | Derivative Exercise and Retained Stock | - | 7,94k | 32,11% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | 45,11k | 0,00 | Derivative Exercise and Retained Stock | - | 224,68k | 25,12% |
| 2026-01-15 | Dr. Brett P. MoniaFounder, CEO & Director | -44,03k | 3,29M | Derivative Exercise and Sale | 74,82 | 224,68k | - |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | 12,28k | 0,00 | Derivative Exercise and Retained Stock | - | 66,17k | 22,79% |
| 2026-01-15 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -9,19k | 697,05k | Derivative Exercise and Sale | 75,84 | 66,17k | - |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | 15,81k | 0,00 | Derivative Exercise and Retained Stock | - | 126,31k | 14,30% |
| 2026-01-15 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -12,92k | 971,99k | Derivative Exercise and Sale | 75,22 | 126,31k | - |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | 6,98k | 0,00 | Derivative Exercise and Retained Stock | - | 14,72k | 90,16% |
| 2026-01-15 | Dr. Holly KordasiewiczExec. VP & Chief Development Officer | -4,14k | 313,31k | Derivative Exercise and Sale | 75,66 | 14,72k | - |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | 5,19k | 0,00 | Derivative Exercise and Retained Stock | - | 16,39k | 46,34% |
| 2026-01-15 | Mr. Kyle JenneExec. VP & Chief Global Product Strategy Officer | -1,82k | 138,48k | Derivative Exercise and Sale | 75,96 | 16,39k | - |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | 11,83k | 0,00 | Derivative Exercise and Retained Stock | - | 45,20k | 35,45% |
| 2026-01-15 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -8,06k | 610,28k | Derivative Exercise and Sale | 75,75 - 75,78 | 45,20k | - |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | 11,61k | 0,00 | Derivative Exercise and Retained Stock | - | 60,44k | 23,78% |
| 2026-01-15 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8,48k | 636,93k | Derivative Exercise and Sale | 75,11 | 60,44k | - |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | 12,08k | 0,00 | Derivative Exercise and Retained Stock | - | 94,76k | 14,61% |
| 2026-01-15 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -8,98k | 674,62k | Derivative Exercise and Sale | 75,15 | 94,76k | - |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | 9,02k | 0,00 | Derivative Exercise and Retained Stock | - | 26,52k | 51,58% |
| 2026-01-15 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -8,35k | 634,41k | Derivative Exercise and Sale | 75,95 | 26,52k | - |
| 2026-01-07 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -44,20k | 1,50M | Derivative Exercise and Sale | 32,60 - 85,36 | 17,49k | - |
| 2026-01-02 | Dr. Eric E. SwayzeExec. VP of Research | -23,46k | 427,66k | Derivative Exercise and Sale | 60,89 - 79,27 | 30,71k | - |
| 2025-12-01 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 2,26M | Automatic Disposition | 80,67 - 81,23 | 52,04k | -34,98% |
| 2025-11-25 | Mr. Joseph KleinIndependent Director | -12,00k | 960,00k | Derivative Exercise and Sale | 80,00 | 16,45k | - |
| 2025-11-25 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -16,78k | 455,34k | Derivative Exercise and Sale | 53,77 - 80,91 | 17,49k | - |
| 2025-11-19 | Ms. Joan Elizabeth HermanIndependent Director | -44,00k | 648,43k | Derivative Exercise and Sale | 40,05 - 72,13 | 46,09k | - |
| 2025-11-18 | Mr. Joseph Harris WenderLead Independent Director | 16,00k | 390,72k | Derivative Exercise and Retained Stock | 24,42 | 80,04k | 24,99% |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -70,93k | 1,15M | Derivative Exercise and Sale | 56,78 - 75,11 | 59,66k | - |
| 2025-11-05 | Dr. Richard S. GearyStrategic Consultant | -34,64k | 576,51k | Derivative Exercise and Sale | 56,78 - 76,10 | 59,66k | - |
| 2025-11-06 | Mr. Brian BirchlerExec. VP of Corporate & Development Operations | -8,00k | 609,38k | Automatic Disposition | 76,17 | 48,83k | -14,08% |
| 2025-10-31 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16,00k | 366,15k | Derivative Exercise and Sale | 52,22 - 75,10 | 36,33k | - |
| 2025-10-31 | Dr. Richard S. GearyStrategic Consultant | -20,00k | 1,50M | Automatic Disposition | 75,11 | 59,66k | -25,11% |
| 2025-10-30 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 2,07M | Automatic Disposition | 72,19 - 75,16 | 64,04k | -30,42% |
| 2025-10-06 | Dr. Brett P. MoniaFounder, CEO & Director | -437,00 | 30,27k | Automatic Disposition | 69,26 | 179,57k | -0,24% |
| 2025-10-06 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -1,63k | 112,73k | Automatic Disposition | 69,37 | 33,37k | -4,64% |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -10,20k | 173,58k | Derivative Exercise and Sale | 52,87 - 69,89 | 53,89k | - |
| 2025-10-06 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -3,24k | 224,49k | Automatic Disposition | 69,27 | 53,89k | -5,67% |
| 2025-10-06 | Dr. Eric E. SwayzeExec. VP of Research | -6,85k | 472,72k | Automatic Disposition | 69,02 | 30,64k | -18,27% |
| 2025-10-02 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -15,00k | 543,21k | Derivative Exercise and Sale | 31,80 - 68,01 | 35,00k | - |
| 2025-10-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -64,66k | 563,80k | Derivative Exercise and Sale | 56,78 - 67,69 | 57,13k | - |
| 2025-10-01 | Mr. Joseph Harris WenderLead Independent Director | -16,80k | 1,10M | Automatic Disposition | 65,50 | 92,04k | -15,44% |
| 2025-10-01 | Dr. Eric E. SwayzeExec. VP of Research | -27,11k | 335,82k | Derivative Exercise and Sale | 53,77 - 66,23 | 37,49k | - |
| 2025-09-29 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -25,30k | 198,39k | Derivative Exercise and Sale | 56,78 - 64,68 | 57,13k | - |
| 2025-09-30 | Ms. Elizabeth L. HougenExec. VP of Finance & CFO | -49,80k | 571,99k | Derivative Exercise and Sale | 53,77 - 65,26 | 110,50k | - |
| 2025-09-30 | Dr. Richard S. GearyStrategic Consultant | -57,90k | 664,39k | Derivative Exercise and Sale | 53,77 - 65,24 | 79,66k | - |
| 2025-09-12 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -1,70k | 13,26k | Derivative Exercise and Sale | 56,78 - 64,58 | 57,13k | - |
| 2025-09-09 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -21,00k | 81,08k | Derivative Exercise and Sale | 56,78 - 64,56 | 57,13k | - |
| 2025-09-09 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -11,95k | 362,83k | Derivative Exercise and Sale | 31,80 - 62,16 | 35,00k | - |
| 2025-09-05 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -250,00 | 7,55k | Derivative Exercise and Sale | 31,80 - 62,00 | 35,00k | - |
| 2025-09-05 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -6,00k | 357,58k | Automatic Disposition | 59,60 | 82,68k | -6,77% |
| 2025-09-02 | Dr. Eric E. SwayzeExec. VP of Research | -11,13k | 552,86k | Automatic Disposition | 49,22 - 53,68 | 37,49k | -22,89% |
| 2025-09-02 | Mr. Joseph Harris WenderLead Independent Director | -28,00k | 1,61M | Automatic Disposition | 55,04 - 60,14 | 108,84k | -20,46% |
| 2025-09-02 | Ms. B. Lynne ParshallDirector | -20,00k | 1,02M | Automatic Disposition | 50,42 - 51,49 | 66,34k | -23,16% |
| 2025-09-03 | Dr. Brett P. MoniaFounder, CEO & Director | -203,81k | 3,26M | Derivative Exercise and Sale | 32,60 - 61,06 | 180,01k | - |
| 2025-09-03 | Ms. Shannon L. Devers DeversExec. VP & Chief Human Resource Officer | -3,16k | 78,74k | Derivative Exercise and Sale | 32,60 - 61,02 | 15,94k | - |
| 2025-09-02 | Dr. Richard S. GearyStrategic Consultant | -10,00k | 503,67k | Automatic Disposition | 50,37 | 79,66k | -11,15% |
| 2025-09-03 | Mr. Joseph KleinIndependent Director | -28,00k | 1,68M | Derivative Exercise and Sale | 60,00 | 16,45k | - |
| 2025-09-03 | Mr. Joseph T. BaroldiExec. VP & Chief Business Officer | -32,80k | 903,18k | Derivative Exercise and Sale | 31,80 - 62,01 | 35,00k | - |
| 2025-09-03 | Dr. Joseph LoscalzoIndependent Chairman of the Board | -16,00k | 571,65k | Derivative Exercise and Sale | 24,42 - 60,15 | 36,33k | - |
| 2025-09-02 | Mr. Patrick R. O'NeilExec. VP, Chief Legal Officer, General Counsel & Corporate Secretary | -89,90k | 1,34M | Derivative Exercise and Sale | 32,60 - 61,42 | 57,13k | - |
| 2025-09-03 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -46,80k | 331,92k | Derivative Exercise and Sale | 53,77 - 61,50 | 88,68k | - |
| 2025-09-02 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -5,00k | 245,70k | Automatic Disposition | 49,14 | 88,68k | -5,34% |
| 2025-09-03 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -19,66k | 138,41k | Derivative Exercise and Sale | 53,77 - 61,42 | 51,51k | - |
| 2025-08-22 | Ms. Allene Maria DiazIndependent Director | -1,43k | 60,69k | Automatic Disposition | 42,53 | 18,37k | -7,21% |
| 2025-08-18 | Dr. C. Frank BennettExec. VP & Chief Scientific Officer | -10,00k | 113,78k | Derivative Exercise and Sale | 32,60 - 43,98 | 93,47k | - |
| 2025-08-06 | Ms. B. Lynne ParshallDirector | -5,00k | 209,65k | Automatic Disposition | 41,87 - 42,63 | 86,34k | -5,47% |
| 2025-08-05 | Dr. Richard S. GearyStrategic Consultant | -10,00k | 428,59k | Automatic Disposition | 42,86 | 89,49k | -10,05% |
| 2025-08-04 | Dr. Eugene SchneiderExec. VP, Chief Clinical Development & Operations Officer | -9,55k | 408,70k | Automatic Disposition | 42,80 | 51,51k | -15,64% |
| 2025-07-30 | Dr. Brett P. MoniaFounder, CEO & Director | -2,43k | 30,16k | Derivative Exercise and Sale | 32,60 - 45,00 | 179,82k | - |
| 2025-07-15 | Dr. Joseph LoscalzoIndependent Chairman of the Board | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 36,33k | 12,65% |
| 2025-07-15 | Mr. Joseph Harris WenderLead Independent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 136,84k | 3,07% |
| 2025-07-15 | Mr. Michael J. YangIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 6,01k | 211,24% |
| 2025-07-15 | Dr. Spencer Robert BerthelsenIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 156,08k | 2,68% |
| 2025-07-15 | Dr. Michael R. HaydenIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 56,30k | 7,81% |
| 2025-07-15 | Ms. Allene Maria DiazIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 19,80k | 25,95% |
| 2025-07-15 | Ms. Joan Elizabeth HermanIndependent Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 46,09k | 9,71% |
| 2025-07-15 | Ms. B. Lynne ParshallDirector | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 91,34k | 4,67% |
| 2025-07-11 | Dr. Brett P. MoniaFounder, CEO & Director | -1,16k | 48,42k | Automatic Disposition | 41,74 | 179,82k | -0,64% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
